Morphocell Technologies completes US$50 million Series A financing, strengthening its foundation for growth in tissue therapeutics. This round was led by Investissement Québec and CDP Venture Capital.
Amount Raised
$50 Million
Round Type
Series A
LavalManufacturingBiotechnologyHealth CareInvestors
Description
Morphocell Technologies Inc. has announced the completion of its US$50 million Series A financing, which included a US$10 million add-on. This financing extension builds on the US$40 million Series A round from February 2024, marking significant progress in tackling liver disease. The support from Investissement Québec and CDP Venture Capital strengthens the company's operational runway
Who to call at Morphocell Technologies, and when
A new round usually means Morphocell Technologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Morphocell Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Morphocell Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Morphocell Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Morphocell Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMorphocell Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.